Head of Investor Relations
Sarepta Therapeutics, Inc. (SRPT)Equibles does not estimate personal net worth.
Get an email with a short summary when Sarepta Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get SRPT alertsTam Thornton is recorded as Head of Investor Relations at Sarepta Therapeutics, Inc. (SRPT). Tam Thornton has spoken on 4 earnings calls across 1 company, most recently for Sarepta Therapeutics, Inc. on November 5, 2026. Sarepta Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Sarepta Therapeutics, Inc. includes Douglas Ingram (CEO and Board Member), Michael Severino, M.D. (CEO and Board Member), M. Kathleen Behrens (Chairman) and 7 others.
“Earlier this afternoon, we released our financial results for the third quarter of 2026. The press release along with our presentation slides and supplementary information are available on the investor section of our company website.”
“Earlier this afternoon, we released our financial results for the first quarter of 2026. The press release, along with our presentation slides and supplementary information, will be available on the Investor section of our company website.”
“Earlier this afternoon, we released our financial results for the fourth quarter of 2025.”
“Earlier this afternoon, we released our financial results for the third quarter of 2025. The press release and slides are available on the investor section of our website at serefta.com, and our 10-Q will be filed with the Securities and Exchange Commission on Thursday aftermarket.”
Biotechnology · Healthcare
Head of Investor Relations
